is semaglutide subcutaneous Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating 7.2 mg for obesity Semaglutide ⏺Type 2 diabetes mellitus
Description
Skin reactions may lessen or disappear as your body gets used to Wegovy
When patients stop taking tirzepatide, weight tends to return within months
If thats true, then stopping GLP-1 RAs would deliver a double whammy: the agent causing increased satiety (and subsequent weight loss) has gone and the bodys normal GLP-1 response to eating is also suppressed
Takeaway: Plateaus Arent Failures
Yes, but consider the timing within the day
The Danger Zone: Room Temperature Leaving your reconstituted Retatrutide vial on the lab bench is a recipe for catastrophic failure
